In silico modeling of phosphorylation dependent and independent c-Myc degradation
暂无分享,去创建一个
Sudipto Saha | Debangana Chakravorty | Tarunendu Mapder | Krishnendu Banerjee | S. Saha | T. Mapder | Krishnendu Banerjee | Debangana Chakravorty
[1] Z. Qu,et al. Roles of Protein Ubiquitination and Degradation Kinetics in Biological Oscillations , 2012, PloS one.
[2] Shinya Kuroda,et al. Prediction and validation of the distinct dynamics of transient and sustained ERK activation , 2005, Nature Cell Biology.
[3] Amit Kumar,et al. Phosphoinositide 3-Kinase Activation in Late G1 Is Required for c-Myc Stabilization and S Phase Entry , 2006, Molecular and Cellular Biology.
[4] Walter Kolch,et al. When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling , 2013, Cell Communication and Signaling.
[5] R. Eisenman,et al. The Myc/Max/Mad network and the transcriptional control of cell behavior. , 2000, Annual review of cell and developmental biology.
[6] S. Leibler,et al. Robustness in simple biochemical networks , 1997, Nature.
[7] Joseph R. Nevins,et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells , 2004, Nature Cell Biology.
[8] K. Nakayama,et al. Degradation of p27 Kip1 at the G0-G1 Transition Mediated by a Skp2-independent Ubiquitination Pathway* , 2001, The Journal of Biological Chemistry.
[9] M. Gregory,et al. c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma Cells , 2000, Molecular and Cellular Biology.
[10] K. Nakayama,et al. Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7 , 2004, The EMBO journal.
[11] Guang Yao,et al. Sensing and Integration of Erk and PI3K Signals by Myc , 2008, PLoS Comput. Biol..
[12] B. Lutterbach,et al. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis , 1994, Molecular and cellular biology.
[13] Sudipto Saha,et al. MYCbase: a database of functional sites and biochemical properties of Myc in both normal and cancer cells , 2017, BMC Bioinformatics.
[14] S. Elledge,et al. Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase , 2001, Science.
[15] S. Elledge,et al. The role of protein stability in the cell cycle and cancer. , 1998, Biochimica et biophysica acta.
[16] Srijeeta Talukder,et al. Deciphering Parameter Sensitivity in the BvgAS Signal Transduction , 2016, PloS one.
[17] S. Kim,et al. Skp2 regulates Myc protein stability and activity. , 2003, Molecular cell.
[18] Lan K. Nguyen,et al. Dynamics of ubiquitin-mediated signalling: insights from mathematical modelling and experimental studies , 2016, Briefings Bioinform..
[19] Michele Pagano,et al. Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis. , 2003, Advances in cancer research.
[20] S. Murray,et al. myc maintains embryonic stem cell pluripotency and self-renewal. , 2010, Differentiation; research in biological diversity.
[21] L. Larsson,et al. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. , 2000, Blood.
[22] Aaron Ciechanover,et al. Proteolysis: from the lysosome to ubiquitin and the proteasome , 2005, Nature Reviews Molecular Cell Biology.
[23] C. Dang,et al. Role of Oncogenic Transcription Factor c-Myc in Cell Cycle Regulation, Apoptosis and Metabolism. , 1997, Journal of biomedical science.
[24] R. Sears,et al. MYC degradation. , 2014, Cold Spring Harbor perspectives in medicine.
[25] L. Penn,et al. The myc oncogene: MarvelouslY Complex. , 2002, Advances in cancer research.
[26] C. Croce,et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Ciechanover,et al. Degradation of MYCN oncoprotein by the ubiquitin system. , 1991, Progress in clinical and biological research.
[28] G. Rangarajan,et al. Disorder, oscillatory dynamics and state switching: the role of c-Myc. , 2015, Journal of theoretical biology.
[29] Chi V Dang,et al. MYC on the Path to Cancer , 2012, Cell.
[30] S. Reed,et al. hCDC4 gene mutations in endometrial cancer. , 2002, Cancer research.
[31] K. Nakayama,et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. , 2003, Molecular cell.
[32] Michele Pagano,et al. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.
[33] R. Eisenman,et al. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells , 1984, Molecular and cellular biology.
[34] John J Tyson,et al. A model for restriction point control of the mammalian cell cycle. , 2004, Journal of theoretical biology.